These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 14529319)
1. Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association. Chatzipanagiotou S; Tsakanikas C; Anagnostouli M; Rentzos M; Ioannidis A; Nicolaou C Mol Diagn; 2003; 7(1):41-3. PubMed ID: 14529319 [TBL] [Abstract][Full Text] [Related]
2. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Derfuss T; Gürkov R; Then Bergh F; Goebels N; Hartmann M; Barz C; Wilske B; Autenrieth I; Wick M; Hohlfeld R; Meinl E Brain; 2001 Jul; 124(Pt 7):1325-35. PubMed ID: 11408328 [TBL] [Abstract][Full Text] [Related]
4. Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls. Sotgiu S; Piana A; Pugliatti M; Sotgiu A; Deiana GA; Sgaramella E; Muresu E; Rosati G Mult Scler; 2001 Dec; 7(6):371-4. PubMed ID: 11795458 [TBL] [Abstract][Full Text] [Related]
5. Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker. Krametter D; Niederwieser G; Berghold A; Birnbaum G; Strasser-Fuchs S; Hartung HP; Archelos JJ Mult Scler; 2001 Feb; 7(1):13-8. PubMed ID: 11321187 [TBL] [Abstract][Full Text] [Related]
6. Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies. Rostasy K; Reiber H; Pohl D; Lange P; Ohlenbusch A; Eiffert H; Maass M; Hanefeld F Neurology; 2003 Jul; 61(1):125-8. PubMed ID: 12847174 [TBL] [Abstract][Full Text] [Related]
7. Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study. Aghaei M; Ashtari F; Bahar M; Falahian MR Neurol Neurochir Pol; 2011; 45(2):128-31. PubMed ID: 21574116 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms. Fainardi E; Castellazzi M; Casetta I; Cultrera R; Vaghi L; Granieri E; Contini C J Neurol Sci; 2004 Feb; 217(2):181-8. PubMed ID: 14706222 [TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Sriram S; Stratton CW; Yao S; Tharp A; Ding L; Bannan JD; Mitchell WM Ann Neurol; 1999 Jul; 46(1):6-14. PubMed ID: 10401775 [TBL] [Abstract][Full Text] [Related]
10. Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis. Hao Q; Miyashita N; Matsui M; Wang HY; Matsushima T; Saida T Mult Scler; 2002 Oct; 8(5):436-40. PubMed ID: 12356213 [TBL] [Abstract][Full Text] [Related]
11. Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis. Parratt J; Tavendale R; O'Riordan J; Parratt D; Swingler R Mult Scler; 2008 Apr; 14(3):292-9. PubMed ID: 18208884 [TBL] [Abstract][Full Text] [Related]
12. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms. Fainardi E; Castellazzi M; Tamborino C; Seraceni S; Tola MR; Granieri E; Contini C J Neurovirol; 2009 Sep; 15(5-6):425-33. PubMed ID: 20053141 [TBL] [Abstract][Full Text] [Related]
16. Chlamydophila pneumoniae infection of the central nervous system in patients with multiple sclerosis. Furrows SJ; Hartley JC; Bell J; Silver N; Losseff N; Stevenson S; Chapman M; Thompson EJ; Ridgway GL; Giovannoni G J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):152-4. PubMed ID: 14707329 [TBL] [Abstract][Full Text] [Related]
17. Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS. Boman J; Roblin PM; Sundström P; Sandström M; Hammerschlag MR Neurology; 2000 Jan; 54(1):265. PubMed ID: 10636169 [No Abstract] [Full Text] [Related]
18. Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis. Fainardi E; Castellazzi M; Seraceni S; Granieri E; Contini C Curr Neurovasc Res; 2008 Feb; 5(1):60-70. PubMed ID: 18289023 [TBL] [Abstract][Full Text] [Related]
19. PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids. Ikejima H; Haranaga S; Takemura H; Kamo T; Takahashi Y; Friedman H; Yamamoto Y Clin Diagn Lab Immunol; 2001 May; 8(3):499-502. PubMed ID: 11329447 [TBL] [Abstract][Full Text] [Related]
20. Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Gieffers J; Pohl D; Treib J; Dittmann R; Stephan C; Klotz K; Hanefeld F; Solbach W; Haass A; Maass M Ann Neurol; 2001 May; 49(5):585-9. PubMed ID: 11357948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]